Methodology

All entries for: Kopra Bio, Inc.

March 2, 2026

Kopra Bio, Inc.

Orphan Drug Designation

San Francisco,
1-50 employees

treatment of malignant glioma

Disease Area: Rare Diseases
Source
Scroll to Top